Lack of pathogenicity of immunodominant T and B cell determinants of the nicotinic acetylcholine receptor ε-chain

Journal of Neuroimmunology

Volumn 152, Issue 1-2, 2004, Pages 44-56

  Gaertner, Susanne ^a   De Graaf, Katrien L ^a   Wienhold, Wolfgang ^a   Wiesmüller, Karl Heinz ^b   Melms, Arthur ^a   Weissert, Robert ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b EMC MICROCOLLECTIONS GMBH   (Germany)

Author keywords

Antigens; Autoimmunity; EAMG; Epitopes; experimental autoimmune myasthenia gravis; MG; MHC; MHC of rat; MNC; MOG; mononuclear cell; myasthenia gravis; myelin oligodendrocyte glycoprotein; nAChR; nicotinic acetylcholine receptor; Peptides; Rodent; RT1; T nAChR

Indexed keywords

AUTOANTIGEN; NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; MYASTHENIA GRAVIS; NONHUMAN; PATHOGENICITY; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; RAT STRAIN; T LYMPHOCYTE; TH1 CELL;

EID: 3042558306     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.03.019     Document Type: Article

References (40)

1. Anderson M.S., Venanzi E.S., Klein L., Chen Z., Berzins S.P., Turley S.J., von Boehmer H., Bronson R., Dierich A., Benoist C., Mathis D. Projection of an immunological self shadow within the thymus by the aire protein. Science. 298:2002;1395-1401
2. Berman P.W., Patrick J. Experimental myasthenia gravis. A murine system. J. Exp. Med. 151:1980;204-223
3. Bielekova B., Goodwin B., Richert N., Cortese I., Kondo T., Afshar G., Gran B., Eaton J., Antel J., Frank J.A., McFarland H.F., Martin R. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat. Med. 6:2000;1167-1175
4. Biesecker G., Koffler D. Resistance to experimental autoimmune myasthenia gravis in genetically inbred rats. Association with decreased amounts of in situ acetylcholine receptor-antibody complexes. J. Immunol. 140:1988;3406-3410
5. Bruno R., Sabater L., Tolosa E., Sospedra M., Ferrer-Francesch X., Coll J., Foz M., Melms A., Pujol-Borrell R. Different patterns of nicotinic acetylcholine receptor subunit transcription in human thymus. J. Neuroimmunol. 149:2004;147-159
6. Engel A.G., Lambert E.H., Howard F.M. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clin. Proc. 52:1977;267-280
7. Fujii Y., Lindstrom J. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides. J. Immunol. 140:1988;1830-1837
8. Gaertner S., de Graaf K.L., Olsson T., Weissert R. Immunogenicity of Torpedo acetylcholine receptor in the context of different rat MHC class II haplotypes and non-MHC genomes. Immunogenetics. 56:2004;61-64
9. Gotter J., Brors B., Hergenhahn M., Kyewski B. Medullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes colocalized in chromosomal clusters. J. Exp. Med. 199:2004;155-166
10. Gu Y., Hall Z.W. Immunological evidence for a change in subunits of the acetylcholine receptor in developing and denervated rat muscle. Neuron. 1:1988;117-125
11. Hill M., Beeson D., Moss P., Jacobson L., Bond A., Corlett L., Newsom-Davis J., Vincent A., Willcox N. Early-onset myasthenia gravis: a recurring T-cell epitope in the adult-specific acetylcholine receptor epsilon subunit presented by the susceptibility allele HLA-DR52a. Ann. Neurol. 45:1999;224-231
12. Hoch W., McConville J., Helms S., Newsom-Davis J., Melms A., Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat. Med. 7:2001;365-368
13. Klein L., Klugmann M., Nave K.A., Tuohy V.K., Kyewski B. Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nat. Med. 6:2000;56-61
14. Kuchroo V.K., Anderson A.C., Waldner H., Munder M., Bettelli E., Nicholson L.B. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 20:2002;101-123
15. Lennon V.A., Lindstrom J.M., Seybold M.E. Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs. J. Exp. Med. 141:1975;1365-1375
16. Lennon V.A., Lambert E.H., Leiby K.R., Okarma T.B., Talib S. Recombinant human acetylcholine receptor alpha-subunit induces chronic experimental autoimmune myasthenia gravis. J. Immunol. 146:1991;2245-2248
17. Lindstrom J., Peng X., Kuryatov A., Lee E., Anand R., Gerzanich V., Wang F., Wells G., Nelson M. Molecular and antigenic structure of nicotinic acetylcholine receptors. Ann. N. Y. Acad. Sci. 841:1998;71-86
18. Madsen L.S., Andersson E.C., Jansson L., krogsgaard M., Andersen C.B., Engberg J., Strominger J.L., Svejgaard A., Hjorth J.P., Holmdahl R., Wucherpfennig K.W., Fugger L. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat. Genet. 23:1999;343-347
19. Martin R., McFarland H.F., McFarlin D.E. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10:1992;153-187
20. Melms A., Schalke B.C., Kirchner T., Muller-Hermelink H.K., Albert E., Wekerle H. Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. J. Clin. Invest. 81:1988;902-908
21. Melms A., Malcherek G., Gern U., Wietholter H., Muller C.A., Schoepfer R., Lindstrom J. T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: heterogeneity of antigenic sites on the alpha-subunit. Ann. Neurol. 31:1992;311-318
22. Missias A.C., Chu G.C., Klocke B.J., Sanes J.R., Merlie J.P. Maturation of the acetylcholine receptor in skeletal muscle: regulation of the AChR gamma-to-epsilon switch. Dev. Biol. 179:1996;223-238
23. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I.R., Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5:1999;49-55
24. Moiola L., Galbiati F., Martino G., Amadio S., Brambilla E., Comi G., Vincent A., Grimaldi L.M., Adorini L. IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody mediated disease. Eur. J. Immunol. 28:1998;2487-2497
25. Muraro P.A., Wandinger K.P., Bielekova B., Gran B., Marques A., Utz U., McFarland H.F., Jacobson S., Martin R. Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders. Brain. 126:2003;20-31
26. Olsson T., Lidman O., Piehl F. Harm or heal-divergent effects of autoimmune neuroinflammation? Trends Immunol. 24:2003;5-6. (author reply 7-8)
27. Patrick J., Lindstrom J. Autoimmune response to acetylcholine receptor. Science. 180:1973;871-872
28. Pirskanen R. Genetic associations between myasthenia gravis and the HL-A system. J. Neurol. Neurosurg. Psychiatry. 39:1976;23-33
29. Salvetti M., Jung S., Chang S.F., Will H., Schalke B.C., Wekerle H. Acetylcholine receptor-specific T-lymphocyte clones in the normal human immune repertoire: target epitopes. HLA restriction, and membrane phenotypes. Ann. Neurol. 29:1991;508-516
30. Sharshar T., Lacroix-Desmazes S., Mouthon L., Kaveri S., Gajdos P., Kazatchkine M.D. Selective impairment of serum antibody repertoires toward muscle and thymus antigens in patients with seronegative and seropositive myasthenia gravis. Eur. J. Immunol. 28:1998;2344-2354
31. Toyka K.V., Brachman D.B., Pestronk A., Kao I. Myasthenia gravis: passive transfer from man to mouse. Science. 190:1975;397-399
32. Tzartos S.J., Barkas T., Cung M.T., Mamalaki A., Marraud M., Orlewski P., Papanastasiou D., Sakarellos C., Sakarellos-Daitsiotis M., Tsantili P., Tsikaris V. Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor. Immunol. Rev. 163:1998;89-120
33. Tzartos S.J., Kokla A., Walgrave S.L., Conti-Tronconi B.M. Localization of the main immunogenic region of human muscle acetylcholine receptor to residues 67-76 of the alpha subunit. Proc. Natl. Acad. Sci. U. S. A. 85:1988;2899-2903
34. Vincent A. Unravelling the pathogenesis of myasthenia gravis. Nat. Rev., Immunol. 2:2002;797-804
35. Voltz R., Kamm C., Padberg F., Malotka J., Kerschensteiner M., Spuler S., Tzartos S., Dornmair K. Highly purified oligo-His tagged human recombinant alpha(1)-AChR is immunogenic in vivo and suitable for T cell stimulation in vitro in experimental and human myasthenia gravis. J. Neuroimmunol. 80:1997;131-136
36. Wanstrat A., Wakeland E. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat. Immunol. 2:2001;802-809
37. Weissert R., Wallstrom E., Storch M.K., Stefferl A., Lorentzen J., Lassmann H., Linington C., Olsson T. MHC haplotype-dependent regulation of MOG-induced EAE in rats. J. Clin. Invest. 102:1998;1265-1273
38. Weissert R., de Graaf K.L., Storch M.K., Barth S., Linington C., Lassmann H., Olsson T. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J. Immunol. 166:2001;7588-7599
39. Weissert R., Kuhle J., de Graaf K.L., Wienhold W., Herrmann M.M., Muller C., Forsthuber T.G., Wiesmuller K.H., Melms A. High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes. J. Immunol. 169:2002;548-556
40. Yoles E., Hauben E., Palgi O., Agranov E., Gothilf A., Cohen A., Kuchroo V., Cohen I.R., Weiner H., Schwartz M. Protective autoimmunity is a physiological response to CNS trauma. J. Neurosci. 21:2001;3740-3748